Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance
An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement
Mantle cell lymphoma – where precision medicine based on response-adapted treatment strategies could show its full worth
Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic
Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma
Potentials, challenges and future of chimeric antigen receptor T-cell therapy in non-Hodgkin lymphomas